Table 5 Results: Primary Outcomes
Gingival Index | ||||||
|---|---|---|---|---|---|---|
Group A Baseline | Group A End of Study | Level of Significance | Group B Baseline | Group B End of Study | Level of Significance | |
Baumgartner et al., 2009 | N/A | N/A | N/A | 0.38 | 0.43 | Not stat. significant |
Woelber et al., 2016 | 1.01 ± 0.14 | 1.22±0.17 | p < 0.001 | 1.10 ±0.51 | 0.54±0.30 | p < 0.001 |
El Makaky et al., 2019 | 1.445 ± 0.4084 | 1.660 ± 0.3775 | p=0.000 | 1.450 ± 0.4335 | 1.145 ± 0.4443 | p=0.000 |
Woelber et al., 2019 | 0.92 ±0.25 | 0.74 ± 0.18 | p < 0.05 | 1.03 ± 0.21 | 0.61 ± 0.29 | p < 0.05 |
Bleeding on Probing (%) | ||||||
Group A Baseline | Group A End of Study | Level of Significance | Group B Baseline | Group B End of Study | Level of Significance | |
Baumgartner et al., 2009 | N/A | N/A | N/A | 34.8% | 12.6% | p < 0.001 |
Woelber et al., 2016 | 46.46% ±15.61 | 64.06% ± 11.27 | p=0.012 | 53.57% ±18.65 | 24.17% ±11.57 | p=0.012 |
El Makaky et al., 2019 | N/A | N/A | N/A | N/A | N/A | N/A |
Woelber et al., 2019 | 28.39% ± 13.32 | 27.09% ± 10.03 | p=0.864 | 30.35% ± 11.07 | 23.55% ± 13.61 | p=0.864 |